Skip to main content
Premium Trial:

Request an Annual Quote

Michael J. Fox Foundation Gives $1.1M for Parkinson's Biomarker Development

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Michael J. Fox Foundation announced today it is providing about $1.1 million to two projects to develop protein candidate biomarkers for Parkinson's disease.

The two markers are alpha-synuclein and DJ-1. On the first marker, MJFF is coordinating a "series of projects" with contract research organizations to optimize assays based on the protein, it said in a statement. Mark Frasier, associate director of research programs at MJFF, will lead the research, which is being conducted with Covance, Epitomics, and Parexel International.

The foundation is also working with Covance and Un Kang, a professor of neurology and director of the Parkinson's Disease and Movement Disorders Center at the University of Chicago Medical Center, to develop DJ-1 assays.

The alpha-synuclein and DJ-1 assays will be tested as part of the foundation's Parkinson's Progression Markers Initiative, a comprehensive biomarker discovery and verification effort.

The Brin Wojcicki Foundation is also providing support for the two projects, MJFF said without elaborating.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.